Research Paper Volume 9, Issue 3 pp 914—931
Overexpression of Rab1B and MMP9 predicts poor survival and good response to chemotherapy in patients with colorectal cancer
Figure 5. Rab1B and MMP9 protein expression predicts outcome of adjuvant chemotherapy in CRC patients. Patients with CRC were stratified into high- or low-expression group by Rab1B or MMP9 expression. (A) Kaplan-Meier survival and Log-rank test were used to compare OS and PFS of CRC patients with or without adjuvant chemotherapy in low Rab1B expression group. (B) OS and PFS of CRC patients with or without adjuvant chemotherapy in the high Rab1B expression group. (C) OS and PFS of CRC patients with or without adjuvant chemotherapy in the low MMP9 expression group. (D) OS and PFS of patients with or without adjuvant chemotherapy in the high MMP9 expression group.